Key result
Differentiating constrictive pericardial disease from restrictive cardiomyopathy is crucial for invasive cardiologists due to the life-changing benefits and considerable risks of surgical treatment.
Why the study?
Differentiating constrictive pericardial disease from restrictive cardiomyopathy is critical because surgical treatment of constriction can be life changing but carries considerable risk.
Differentiating constrictive pericardial disease from restrictive cardiomyopathy is crucial for invasive cardiologists due to the life-changing potential and considerable risk of surgical treatment for constriction.
Differentiation warrants rigorous pre-surgical evaluation; leaves open prospective validation of diagnostic algorithms.
Clinical presentations of dyspnea, pedal edema, enlarged liver, and jugular venous distention may require differentiating constrictive pericardial disease (CPD) from restrictive cardiomyopathy (RCM). Differentiation of the pathophysiology is of paramount importance to the invasive cardiologist because they are often called to sort out a confusing clinical picture. The surgical treatment of pericardial constriction not only can be life changing for the patient but also involves a considerable risk.
No takes yet. Share an insight, caveat, or question.
Dean et al. (2023) conducted a review in Constrictive pericardial disease (CPD) and restrictive cardiomyopathy (RCM). Differentiating constrictive pericardial disease from restrictive cardiomyopathy is crucial for invasive cardiologists due to the life-changing benefits and considerable risks of surgical treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: